Warehouse Overstock Promotion |  Save 10%  on Premium Lab Supplies |  Shop Now

Menu

This product has been added to the cart.

Recombinant Human Calreticulin-3/CALR3 Protein

SKU: PKSH032151-50

  • $ 40295
  • Save $ 4900


Request a Quote

Recombinant Human Calreticulin-3/CALR3 Protein

 

SKU # PKSH032151
Expression Host E.coli

 

 

Description

Synonyms CALR3, CRT2, Calreticulin-3, calreticulin-2, calsperin
Species Human
Expression Host E.coli
Sequence Thr 20-Leu384
Accession Q96L12
Calculated Molecular Weight 42.9 kDa
Observed Molecular Weight 40-50 kDa
Tag None
Bio-activity Not validated for activity
  

 

Properties

Purity > 95 % as determined by reducing SDS-PAGE.
Endotoxin < 1.0 EU per μg of the protein as determined by the LAL method.
Storage Generally, lyophilized proteins are stable for up to 12 months when stored at -20 to -80℃. Reconstituted protein solution can be stored at 4-8℃ for 2-7 days. Aliquots of reconstituted samples are stable at < -20℃ for 3 months.
Shipping This product is provided as lyophilized powder which is shipped with ice packs.
Formulation Lyophilized from a 0.2 μm filtered solution of 20mM Tris-HCl, 150mM NaCl, 5% Trehalose, 5% Mannitol, 0.02% Tween 80, 1mM EDTA, pH8.0.
Normally 5% - 8% trehalose, mannitol and 0.01% Tween 80 are added as protectants before lyophilization.
Please refer to the specific buffer information in the printed manual.
Reconstitution Please refer to the printed manual for detailed information.



Background

Calreticulin-3 belongs to the calreticulin family, members of which are calcium binding chaperones localized mainly in the endoplasmic reticulum. It can be divided into a N-terminal globular domain, a proline-rich P-domain forming an elongated arm-like structure and a C-terminal acidic domain. During spermatogenesis process, Calreticulin-3 may act as a lectin-independent chaperone for specific client proteins such as ADAM3. Defects in CALR3 are the cause of familial hypertrophic cardiomyopathy type 19 (CMH19), it is a hereditary heart disorder characterized by ventricular hypertrophy, which is usually asymmetric and often involves the interventricular septum. The symptoms include dyspnea, syncope, collapse, palpitations, and chest pain.